Mirae Asset Global Etfs Holdings Ltd. Janux Therapeutics, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.4 Billion
- Q1 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Janux Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 21,403 shares of JANX stock, worth $535,289. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,403
Previous 18,010
18.84%
Holding current value
$535,289
Previous $964,000
40.15%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding JANX
# of Institutions
193Shares Held
57.3MCall Options Held
626KPut Options Held
155K-
Ra Capital Management, L.P. Boston, MA11.2MShares$280 Million6.27% of portfolio
-
Janus Henderson Group PLC London, X04.6MShares$115 Million0.07% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.65MShares$91.4 Million0.19% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY3.33MShares$83.3 Million4.61% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$58.6 Million0.0% of portfolio
About Janux Therapeutics, Inc.
- Ticker JANX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,663,000
- Market Cap $1.04B
- Description
- Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth ...